000 | 01570 a2200433 4500 | ||
---|---|---|---|
005 | 20250513101504.0 | ||
264 | 0 | _c19961204 | |
008 | 199612s 0 0 eng d | ||
022 | _a0147-8389 | ||
024 | 7 |
_a10.1111/j.1540-8159.1996.tb03307.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStark, G | |
245 | 0 | 0 |
_aHow to measure AV nodal refractoriness in the presence of verapamil, amiodarone, digoxin, and diltiazem. _h[electronic resource] |
260 |
_bPacing and clinical electrophysiology : PACE _cFeb 1996 |
||
300 |
_a157-64 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmiodarone _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aAtrioventricular Node _xdrug effects |
650 | 0 | 4 | _aCardiac Pacing, Artificial |
650 | 0 | 4 |
_aDigoxin _xpharmacology |
650 | 0 | 4 |
_aDiltiazem _xpharmacology |
650 | 0 | 4 |
_aElectrocardiography _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFourier Analysis |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 |
_aHeart Rate _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aSignal Processing, Computer-Assisted |
650 | 0 | 4 |
_aVerapamil _xpharmacology |
700 | 1 | _aKasper, K | |
700 | 1 | _aSchulze-Bauer, C | |
700 | 1 | _aStark, U | |
700 | 1 | _aDecrinis, M | |
700 | 1 | _aTritthart, H A | |
773 | 0 |
_tPacing and clinical electrophysiology : PACE _gvol. 19 _gno. 2 _gp. 157-64 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1540-8159.1996.tb03307.x _zAvailable from publisher's website |
999 |
_c8828886 _d8828886 |